FDA Enforcement Class II Ongoing

CellaVision DM Software versions 6.0.1 or 6.0.2 installed on the following products: CellaVision DM96, DM1200, DM9600 and DI-60 Product Usage: The devices are automated cell-locating devices. The devices automatically locates and presents images of blood cells on peripheral blood smears. The operator identifies and verifies the suggested classification of each cell according to type. The devices are intended to be used by skilled operators, trained in the use of the device and in recognition of blood cells

Recall: Z-2184-2018 · Reported June 20, 2018

Enforcement

Recall Number
Z-2184-2018
Event ID
80137
Classification
Class II
Status
Ongoing
Product Type
Devices
Firm
Cellavision AB
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Report Date
June 20, 2018
Initiation Date
December 4, 2017
Classification Date
June 13, 2018
Address
Forskningsbyn Ideon, Scheelevagen 19a, Lund, N/A, N/A, Sweden

Description

CellaVision DM Software versions 6.0.1 or 6.0.2 installed on the following products: CellaVision DM96, DM1200, DM9600 and DI-60 Product Usage: The devices are automated cell-locating devices. The devices automatically locates and presents images of blood cells on peripheral blood smears. The operator identifies and verifies the suggested classification of each cell according to type. The devices are intended to be used by skilled operators, trained in the use of the device and in recognition of blood cells

Reason

A software malfunction was found where WBC, RBC and PLT comments added after a slide is signed, are not sent to the LIS. This can only occur where customers process multiple slides per blood sample.

Code Info

Versions 6.0.1 or 6.0.2

Distribution

US Nationwide in the states of FL, IL, NY, and NC

Quantity

Instruments: 224 Software: 99 (US)